US 9211328
Modulation of NKG2D for prolonging survival of a hematopoietic graft
granted A61KA61K2039/505A61K39/39541
Quick answer
US patent 9211328 (Modulation of NKG2D for prolonging survival of a hematopoietic graft) held by The Regents of the University of California expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K39/39541, A61P, A61P1/00